InMed Pharmaceuticals (INM) Operating Income Growth (1y) (2022 - 2025)
InMed Pharmaceuticals (INM) Operating Income Growth (1y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | -150.77% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -10.00% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | -0.93% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | -9.25% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -97.30% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 4.05% |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 12.73% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | InMed Pharmaceuticals | 6.64 Mn | 1.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.72% |
| Sep 30, 2025 | -4.94% |
| Jun 30, 2025 | -21.33% |
| Mar 31, 2025 | -3.45% |
| Dec 31, 2024 | -37.03% |
| Sep 30, 2024 | 35.09% |
| Jun 30, 2024 | -319.30% |
| Mar 31, 2024 | 14.29% |
| Dec 31, 2023 | 25.70% |
| Sep 30, 2023 | 25.26% |
| Jun 30, 2023 | 92.56% |
| Mar 31, 2023 | 39.20% |
| Dec 31, 2022 | 48.66% |